335 related articles for article (PubMed ID: 34360719)
1. Uncovering the Mechanisms of Adenosine Receptor-Mediated Pain Control: Focus on the A
Coppi E; Cherchi F; Lucarini E; Ghelardini C; Pedata F; Jacobson KA; Di Cesare Mannelli L; Pugliese AM; Salvemini D
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360719
[TBL] [Abstract][Full Text] [Related]
2. Adenosine A3 receptor activation inhibits pronociceptive N-type Ca2+ currents and cell excitability in dorsal root ganglion neurons.
Coppi E; Cherchi F; Fusco I; Failli P; Vona A; Dettori I; Gaviano L; Lucarini E; Jacobson KA; Tosh DK; Salvemini D; Ghelardini C; Pedata F; Di Cesare Mannelli L; Pugliese AM
Pain; 2019 May; 160(5):1103-1118. PubMed ID: 31008816
[TBL] [Abstract][Full Text] [Related]
3. Covalently Binding Adenosine A
Cherchi F; Venturini M; Magni G; Scortichini M; Jacobson KA; Pugliese AM; Coppi E
Purinergic Signal; 2024 Feb; 20(1):35-45. PubMed ID: 36918461
[TBL] [Abstract][Full Text] [Related]
4. Targeting the A
Singh AK; Mahalingam R; Squillace S; Jacobson KA; Tosh DK; Dharmaraj S; Farr SA; Kavelaars A; Salvemini D; Heijnen CJ
Acta Neuropathol Commun; 2022 Jan; 10(1):11. PubMed ID: 35093182
[TBL] [Abstract][Full Text] [Related]
5. Acute visceral pain relief mediated by A3AR agonists in rats: involvement of N-type voltage-gated calcium channels.
Lucarini E; Coppi E; Micheli L; Parisio C; Vona A; Cherchi F; Pugliese AM; Pedata F; Failli P; Palomino S; Wahl J; Largent-Milnes TM; Vanderah TW; Tosh DK; Jacobson KA; Salvemini D; Ghelardini C; Di Cesare Mannelli L
Pain; 2020 Sep; 161(9):2179-2190. PubMed ID: 32379223
[TBL] [Abstract][Full Text] [Related]
6. Chronic Morphine-Induced Changes in Signaling at the A
Doyle TM; Largent-Milnes TM; Chen Z; Staikopoulos V; Esposito E; Dalgarno R; Fan C; Tosh DK; Cuzzocrea S; Jacobson KA; Trang T; Hutchinson MR; Bennett GJ; Vanderah TW; Salvemini D
J Pharmacol Exp Ther; 2020 Aug; 374(2):331-341. PubMed ID: 32434943
[TBL] [Abstract][Full Text] [Related]
7. Adenosine A3 agonists reverse neuropathic pain via T cell-mediated production of IL-10.
Durante M; Squillace S; Lauro F; Giancotti LA; Coppi E; Cherchi F; Di Cesare Mannelli L; Ghelardini C; Kolar G; Wahlman C; Opejin A; Xiao C; Reitman ML; Tosh DK; Hawiger D; Jacobson KA; Salvemini D
J Clin Invest; 2021 Apr; 131(7):. PubMed ID: 33621215
[TBL] [Abstract][Full Text] [Related]
8. Spinal neuroimmune activation is independent of T-cell infiltration and attenuated by A3 adenosine receptor agonists in a model of oxaliplatin-induced peripheral neuropathy.
Janes K; Wahlman C; Little JW; Doyle T; Tosh DK; Jacobson KA; Salvemini D
Brain Behav Immun; 2015 Feb; 44():91-9. PubMed ID: 25220279
[TBL] [Abstract][Full Text] [Related]
9. A3 adenosine receptor agonist prevents the development of paclitaxel-induced neuropathic pain by modulating spinal glial-restricted redox-dependent signaling pathways.
Janes K; Esposito E; Doyle T; Cuzzocrea S; Tosh DK; Jacobson KA; Salvemini D
Pain; 2014 Dec; 155(12):2560-2567. PubMed ID: 25242567
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic Potential of Highly Selective A
Coppi E; Cherchi F; Venturini M; Lucarini E; Corradetti R; Di Cesare Mannelli L; Ghelardini C; Pedata F; Pugliese AM
Molecules; 2022 Mar; 27(6):. PubMed ID: 35335254
[TBL] [Abstract][Full Text] [Related]
11. Engagement of the GABA to KCC2 signaling pathway contributes to the analgesic effects of A3AR agonists in neuropathic pain.
Ford A; Castonguay A; Cottet M; Little JW; Chen Z; Symons-Liguori AM; Doyle T; Egan TM; Vanderah TW; De Koninck Y; Tosh DK; Jacobson KA; Salvemini D
J Neurosci; 2015 Apr; 35(15):6057-67. PubMed ID: 25878279
[TBL] [Abstract][Full Text] [Related]
12. Molecular dissection of the human A
Storme J; Cannaert A; Van Craenenbroeck K; Stove CP
Biochem Pharmacol; 2018 Feb; 148():298-307. PubMed ID: 29309765
[TBL] [Abstract][Full Text] [Related]
13. Endogenous adenosine A3 receptor activation selectively alleviates persistent pain states.
Little JW; Ford A; Symons-Liguori AM; Chen Z; Janes K; Doyle T; Xie J; Luongo L; Tosh DK; Maione S; Bannister K; Dickenson AH; Vanderah TW; Porreca F; Jacobson KA; Salvemini D
Brain; 2015 Jan; 138(Pt 1):28-35. PubMed ID: 25414036
[TBL] [Abstract][Full Text] [Related]
14. The Histamine H
Micheli L; Durante M; Lucarini E; Sgambellone S; Lucarini L; Di Cesare Mannelli L; Ghelardini C; Masini E
Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680083
[TBL] [Abstract][Full Text] [Related]
15. IB-MECA, an A3 adenosine receptor agonist prevents bone resorption in rats with adjuvant induced arthritis.
Rath-Wolfson L; Bar-Yehuda S; Madi L; Ochaion A; Cohen S; Zabutti A; Fishman P
Clin Exp Rheumatol; 2006; 24(4):400-6. PubMed ID: 16956430
[TBL] [Abstract][Full Text] [Related]
16. An adenosine A3 receptor agonist inhibits DSS-induced colitis in mice through modulation of the NF-κB signaling pathway.
Ren T; Tian T; Feng X; Ye S; Wang H; Wu W; Qiu Y; Yu C; He Y; Zeng J; Cen J; Zhou Y
Sci Rep; 2015 Mar; 5():9047. PubMed ID: 25762375
[TBL] [Abstract][Full Text] [Related]
17. A
Terayama R; Tabata M; Maruhama K; Iida S
Exp Brain Res; 2018 Dec; 236(12):3203-3213. PubMed ID: 30206669
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of the adenosine A3 receptor, not the A1 or A2 receptors, promote neurite outgrowth of retinal ganglion cells.
Nakashima KI; Iwao K; Inoue T; Haga A; Tsutsumi T; Mochita MI; Fujimoto T; Tanihara H
Exp Eye Res; 2018 May; 170():160-168. PubMed ID: 29486164
[TBL] [Abstract][Full Text] [Related]
19. Adenosine A
Farr SA; Cuzzocrea S; Esposito E; Campolo M; Niehoff ML; Doyle TM; Salvemini D
J Neuroinflammation; 2020 Nov; 17(1):339. PubMed ID: 33183330
[TBL] [Abstract][Full Text] [Related]
20. Cl-IB-MECA inhibits human thyroid cancer cell proliferation independently of A3 adenosine receptor activation.
Morello S; Petrella A; Festa M; Popolo A; Monaco M; Vuttariello E; Chiappetta G; Parente L; Pinto A
Cancer Biol Ther; 2008 Feb; 7(2):278-84. PubMed ID: 18059189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
